OptimizeRx Corporation
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Stephen L. Silvestro
- Full Time Employees
- 128
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 400 Water Street Waltham MI United States of America 48307
- IPO Date
- Nov 28, 2007
- CIK
- 0001448431
- Website
- optimizerx.com
- Similar Companies
- Business
- OptimizeRx Corporation operates as a leading digital health technology provider, creating essential connections among life science organizations, healthcare professionals, and patients. The company’s integrated solutions are designed to optimize engagements throughout the patient journey. Its core offerings include a robust omnichannel platform that facilitates crucial communications through an extensive network, reaching over two million U.S. healthcare providers and millions of patients. Among its advanced capabilities is the Dynamic Audience Activation Platform (DAAP), which leverages artificial intelligence and machine learning for predictive analytics to generate precise audiences and execute dynamic marketing strategies. Complementing this is Micro-Neighborhood Targeting (MNT), a patented, privacy-safe technology that identifies consumer audiences based on disease prevalence and clinical indicators, enabling highly localized and targeted outreach for both direct-to-consumer (DTC) and out-of-home advertising efforts. OptimizeRx also delivers financial messaging, providing prescribers with direct visibility to branded co-pay offers, sample programs, and various financial assistance options embedded within electronic health record (EHR) and e-prescribing systems. Its brand and clinical messaging services encompass awareness campaigns, therapeutic support, affordability messaging, information on patient support hubs, details on limited distribution drugs, and general patient support communications. Furthermore, the company offers patient engagement solutions, including mobile health platforms for interactive messaging, enhanced medication adherence, and care coordination, along with HIPAA-compliant automated mobile messaging for direct patient interaction to improve regimen compliance. Pharmacy alert systems are also in place to inform providers about prescription medication stock status. The company’s strategic initiatives include its 2023 acquisition of Medicx Health, which significantly expanded its direct-to-consumer marketing reach and integrated the Micro-Neighborhood Targeting Platform into its offerings. More recently, in September 2025, OptimizeRx formed a strategic partnership with Lamar Advertising to integrate MNT data with Lamar's national inventory, enhancing targeted out-of-home advertising for healthcare brands. Founded in 2006, OptimizeRx Corporation is now headquartered in Waltham, Massachusetts.
OptimizeRx to Participate in Upcoming Investor Conferences
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet?
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx's Authenticated EHR Network
OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?
OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds
OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?
OptimizeRx Q1 Earnings Call Highlights
OptimizeRx Corporation (OPRX) Q1 2026 Earnings Call Transcript
OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
OptimizeRx Expands EHR Advertising Reach With New DSP Integration
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?
Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline
Are Investors Undervaluing OptimizeRx (OPRX) Right Now?
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
Cadence Design Systems (CDNS) Q1 Earnings and Revenues Top Estimates